false Q1 2025 --06-30 0001836754 P10Y P7Y 四年 0001836754 2024-07-01 2024-09-30 0001836754 2024-11-12 0001836754 2024-09-30 0001836754 2024-06-30 0001836754 2023-07-01 2023-09-30 0001836754 us-gaap:优先股票成员 2024-06-30 0001836754 us-gaap:普通股成员 2024-06-30 0001836754 us-gaap:额外实收资本成员 2024-06-30 0001836754 us-gaap:留存收益成员 2024-06-30 0001836754 us-gaap:优先股票成员 2023-06-30 0001836754 us-gaap:普通股成员 2023-06-30 0001836754 us-gaap:额外实收资本成员 2023-06-30 0001836754 us-gaap:留存收益成员 2023-06-30 0001836754 2023-06-30 0001836754 us-gaap:优先股票成员 2024-07-01 2024-09-30 0001836754 us-gaap:普通股成员 2024-07-01 2024-09-30 0001836754 us-gaap:额外实收资本成员 2024-07-01 2024-09-30 0001836754 us-gaap:留存收益成员 2024-07-01 2024-09-30 0001836754 us-gaap:优先股票成员 2023-07-01 2023-09-30 0001836754 us-gaap:普通股成员 2023-07-01 2023-09-30 0001836754 us-gaap:额外实收资本成员 2023-07-01 2023-09-30 0001836754 us-gaap:留存收益成员 2023-07-01 2023-09-30 0001836754 us-gaap:优先股票成员 2024-09-30 0001836754 us-gaap:普通股成员 2024-09-30 0001836754 us-gaap:额外实收资本成员 2024-09-30 0001836754 us-gaap:留存收益成员 2024-09-30 0001836754 us-gaap:优先股票成员 2023-09-30 0001836754 us-gaap:普通股成员 2023-09-30 0001836754 us-gaap:额外实收资本成员 2023-09-30 0001836754 us-gaap:留存收益成员 2023-09-30 0001836754 2023-09-30 0001836754 LGCY : 遗产教育合并子公司有限责任公司成员 2021-09-03 2021-09-03 0001836754 LGCY : 遗产教育合并子公司有限责任公司成员 2021-09-03 0001836754 美国通用会计准则:家具和设备成员 2024-09-30 0001836754 美国通用会计准则:机器设备成员 2024-09-30 0001836754 美元指数:计算机设备成员 2024-09-30 0001836754 美国通用会计准则:车辆会员 2024-09-30 0001836754 2022-07-01 0001836754 2022-07-01 2022-07-01 0001836754 LGCY : 课程大纲成员 2024-09-30 0001836754 2023-07-01 2024-06-30 0001836754 us-gaap:逐渐转移成员 LGCY : 学费和实验室费用成员 2024-07-01 2024-09-30 0001836754 us-gaap:逐渐转移成员 LGCY : 学费和实验室费用成员 2023-07-01 2023-09-30 0001836754 美元指数:在某一时点转移的成员 LGCY : 书籍注册与其他费用会员 2024-07-01 2024-09-30 0001836754 美元指数:在某一时点转移的成员 LGCY : 书籍注册与其他费用会员 2023-07-01 2023-09-30 0001836754 LGCY : 继续教育与培训认证委员会会员 2024-07-01 2024-09-30 0001836754 LGCY : 健康教育学校认证局会员 2024-07-01 2024-09-30 0001836754 美国通用会计准则:租赁权益改良会员 2024-09-30 0001836754 美国通用会计准则:租赁权益改良会员 2024-06-30 0001836754 美国通用会计准则:机器设备成员 2024-06-30 0001836754 美元指数:计算机设备成员 2024-06-30 0001836754 美国通用会计准则:办公设备成员 2024-09-30 0001836754 美国通用会计准则:办公设备成员 2024-06-30 0001836754 2022-07-01 2023-06-30 0001836754 2021-06-30 0001836754 LGCY : 本票成员 2024-07-01 2024-09-30 0001836754 us-gaap:关联方成员 LGCY : 本票成员 2024-07-01 2024-09-30 0001836754 LGCY : 本票成员 2024-09-30 0001836754 LGCY : 本票两个成员 2023-09-01 2023-09-30 0001836754 LGCY : 设备贷款会员 LGCY : 本票会员 2023-01-31 0001836754 LGCY : 设备贷款会员 LGCY : 本票会员 2023-01-01 2023-01-31 0001836754 LGCY : 设备贷款会员 LGCY : 本票会员 2024-09-30 0001836754 LGCY : 设备贷款会员 LGCY : 本票会员 2024-06-30 0001836754 LGCY : 设备贷款一名会员 LGCY : 本票会员 2023-08-31 0001836754 LGCY : 设备贷款一名会员 LGCY : 本票会员 2023-08-01 2023-08-31 0001836754 LGCY : 设备贷款一名会员 LGCY : 本票会员 2024-09-30 0001836754 LGCY : 设备贷款一名会员 LGCY : 本票会员 2024-06-30 0001836754 LGCY : 设备贷款两个会员 LGCY : 票据会员 2023-11-30 0001836754 LGCY : 设备贷款两个会员 LGCY : 票据会员 2023-11-01 2023-11-30 0001836754 LGCY : 设备贷款两个会员 LGCY : 票据会员 2024-09-30 0001836754 LGCY : 设备贷款两个会员 LGCY : 票据会员 2024-06-30 0001836754 LGCY : 设备贷款三成员 LGCY : 贴现票据成员 2023-12-31 0001836754 LGCY : 设备贷款三成员 LGCY : 贴现票据成员 2023-12-01 2023-12-31 0001836754 LGCY : 设备贷款三成员 LGCY : 贴现票据成员 2024-09-30 0001836754 LGCY : 设备贷款三成员 LGCY : 贴现票据成员 2024-06-30 0001836754 LGCY : 设备贷款四成员 LGCY : 本票成员 2024-02-29 0001836754 LGCY : 设备贷款四成员 LGCY : 本票成员 2024-02-01 2024-02-29 0001836754 LGCY : 设备贷款四成员 LGCY : 本票成员 2024-09-30 0001836754 LGCY : 设备贷款四成员 LGCY : 本票成员 2024-06-30 0001836754 LGCY : 设备贷款五个成员 LGCY : 借据成员 2024-06-30 0001836754 LGCY : 设备贷款五个成员 LGCY : 借据成员 2024-06-01 2024-06-30 0001836754 LGCY : 设备贷款五个成员 LGCY : 借据成员 2024-09-30 0001836754 LGCY : 设备贷款六个成员 LGCY : 借据成员 2024-07-31 0001836754 LGCY : 设备贷款六名成员 LGCY : 票据成员 2024-07-01 2024-07-31 0001836754 LGCY : 设备贷款六名成员 LGCY : 票据成员 2024-09-30 0001836754 LGCY : 设备贷款六名成员 LGCY : 票据成员 2024-06-30 0001836754 LGCY : 票据成员 2024-06-30 0001836754 LGCY : 票据成员 us-gaap:关联方成员 2024-09-30 0001836754 LGCY : 本票成员 us-gaap:关联方成员 2024-06-30 0001836754 LGCY : 本票成员 2023-07-01 2024-06-30 0001836754 LGCY : 本票成员 us-gaap:关联方成员 2023-07-01 2024-06-30 0001836754 LGCY : 银行贷款一号成员 2024-09-30 0001836754 LGCY : 银行贷款一号成员 2024-06-30 0001836754 LGCY : 银行贷款两名成员 2024-09-30 0001836754 LGCY : 银行贷款两名成员 2024-06-30 0001836754 LGCY : 银行贷款一名成员 2024-07-01 2024-09-30 0001836754 LGCY : 银行贷款一名成员 2023-07-01 2024-06-30 0001836754 LGCY : 银行贷款两名成员 2024-07-01 2024-09-30 0001836754 LGCY : 银行贷款两名成员 2023-07-01 2024-06-30 0001836754 us-gaap:关联方成员 2024-09-30 0001836754 LGCY : 股东成员 2024-07-01 2024-09-30 0001836754 LGCY : 股东成员 2023-07-01 2023-09-30 0001836754 srt: 董事成员 2024-07-01 2024-09-30 0001836754 srt: 董事成员 2023-07-01 2023-09-30 0001836754 LGCY : 董事一名 2024-07-01 2024-09-30 0001836754 LGCY : 董事一名 2023-07-01 2023-09-30 0001836754 LGCY : 本票成员 srt:高管成员 2019-12-01 2019-12-31 0001836754 LGCY : 本票成员 srt:高管成员 2019-12-31 0001836754 LGCY : 应收票据会员 srt:高管成员 2024-09-30 0001836754 LGCY : 应收票据会员 srt:高管成员 2024-06-30 0001836754 LGCY : 设备贷款会员 2023-07-31 0001836754 LGCY : 设备贷款会员 2023-07-01 2023-07-31 0001836754 LGCY : 设备贷款会员 2024-09-30 0001836754 LGCY : 设备贷款会员 2024-06-30 0001836754 2024-09-09 2024-09-09 0001836754 IPO成员 2024-09-27 2024-09-27 0001836754 IPO成员 2024-09-27 0001836754 LGCY : 时间归属期选择会员 srt : 最小成员 2024-09-30 0001836754 LGCY : 时间归属期选择会员 srt : 最大成员 2024-09-30 0001836754 LGCY : 员工、董事、顾问和非员工会员 LGCY : 二零二一年股票激励计划成员 2024-04-01 2024-04-01 0001836754 us-gaap:普通股成员 2024-08-01 2024-08-31 0001836754 LGCY : 员工、董事、顾问和非员工成员 LGCY : 二零二一年股票激励计划成员 2024-09-27 2024-09-27 0001836754 2024-04-01 2024-04-30 0001836754 2024-04-30 0001836754 2024-09-01 2024-09-30 0001836754 us-gaap:后续事件成员 LGCY : 承销商成员 2024-10-01 2024-10-01 0001836754 us-gaap:后续事件成员 LGCY : 资产购买协议成员 LGCY : Contra Costa 职业医学学院成员 2024-10-22 2024-10-22 iso4217:美元指数 xbrli:股份 iso4217:美元指数 xbrli:股份 xbrli:纯形 平方英尺

 

 

 

美国

证券交易委员会

华盛顿特区20549

 

表格 10-Q

 

根据1934年证券交易法第13或15(d)条款的季度报告。

 

截至年度季度结束 2024年9月30日

 

根据1934年证券交易法第13或15(d)条款的过渡报告

 

在从___到____的过渡期间

 

委员会档案编号: 001-42283

 

传承教育公司

(依凭章程所载的完整登记名称)

 

内华达   84-5167957
(州或其他管辖区   (美国国税局雇主识别号码)
注册或组织)   识别号码)

 

701 W大道K, 套房123 兰开斯特, 加州   93534
(总执行办公室地址)   (邮政编码)

 

(661) 940-9300

(注册人电话号码,包括区号)

 

根据法案第12(b)条规定注册的证券:

 

每个类别的标题   交易 标的   在哪个交易所上市的名字
普通股,每股面值0.001美元   LGCY   纽交所 美国有限责任公司

 

勾选表示公司已按照证券交易法第13或15(d)条款的规定,在过去12个月(或公司需要提交此类报告的较短期限内)提交了所有所需的报告;并且公司在过去90天内一直受到此类提交报告的要求。 Yes ☒ 否 ☐

 

请勾选,指出在过去12个月内(或更短时间并应提供此类文件的情况下),申报人是否已依据Regulation S-t(本章节之§232.405号)提交每一个所需提交的互动式数据文件。 Yes ☒ 否 ☐

 

勾选是否属于大型加速档案提交者、加速档案提交者、非加速档案提交者、较小型报告公司或新兴成长公司。请参见交易所法案第1202条中“大型加速档案提交者”、“加速档案提交者”、“较小型报告公司”和“新兴成长公司”的定义。

 

大型及加速提交者 加速提交者
非加速提交者 较小的报告公司
    新兴成长型公司

 

如为新兴成长企业,则应打勾选项表示申报人已选择不使用交易所法第13(a)条所提供的任何新或修订财务会计准则延长过渡期遵守。

 

请勾选是否登记者为外壳公司(依照交易所法规120亿2的定义)。是 ☐ 否

 

发行人普通股股数,每股面值为$,截至2024年11月12日,已经发行的数量为0.001 ,每股面值为$,截至2024年11月12日 12,244,162.

 

 

 

 
 

 

目录

 

  页面 
第I部分 - 财务资讯 F-1
ITEM 1. 基本报表 F-1
  截至2024年9月30日的简明合并资产负债表(未经审核)及2024年6月30日 F-2
  截至2024年和2023年9月30日的简明合并损益表(未经审核) F-3
  截至2024年和2023年9月30日的简明合并股东权益变动表(未经审核) F-4
  截至2024年和2023年9月30日的简明合并现金流量表(未经审核) F-5
  基本报表未经审核简明合并财务报表注脚 F-6
ITEM 2. 财务状况和业绩的管理讨论和分析 1
项目 3. 市场风险相关数量和质量的披露 9
项目 4. 控制和程序 9
     
第二部分 - 其他信息  
ITEM 1. 法律诉讼 10
项目 1A。 风险因素 10
ITEM 2. 未注册的股票销售和收益使用 10
项目 3. 债券不履行标准 10
项目 4. 矿场安全披露 11
项目5。 其他资讯 11
项目6。 附件 11
签名 12

 

i

 

 

关于前瞻性陈述和行业数据的警语

 

本季度报告表格10-Q内含特定的前瞻性声明,是根据1933年证券法及其修订版(“证券法”)第27A条和1934年证券交易法及其修订版(“交易所法”)第21E条的安全港条款所进行的。本季度报告表格10-Q中的任何关于我们期望、信念、计划、目标、假设或未来事件或表现的陈述均不是历史事实,而是前瞻性声明。这些声明通常并非总是通过使用“可能”、“应该”、“相信”、“将”、“期望”、“预测”、“估计”、“预测”、“潜在”、“持续”、“打算”、“计划”和“将”或这些术语的否定或其他相应术语来进行。例如,有关财务状况、可能或假定的未来营运结果、增长机会和计划的陈述都是前瞻性声明。我们的前瞻性声明基于对我们公司的一系列期望、假设、估计和投影,并不保证未来结果或表现,涉及大量风险和不确定性。它们涉及已知和未知的风险、不确定性和假设,可能导致任何前瞻性声明所表达或暗示的实际结果、活动水平、表现或成就与任何前瞻性声明所暗示的结果、活动水平、表现或成就有实质不同。我们实际上可能无法实现这些前瞻性声明中披露的计划、意向或期望。我们的业务和前瞻性声明涉及包括我们关于的陈述中固有的风险和不确定性。

 

  合规 遵守我们行业适用的庞大现有监管框架或我们未能及时获得和保持监管 批准和认证;
     
  合规 遵守适用的联邦法律和法规的持续变化,包括美国教育部正在进行的未决规则制定;
     
  目前和未来Title IV计划法规的影响,源自协商规定,包括对通过Title IV计划获得的资金可能的减少或使用限制;
     
  成功地更新和扩展现有节目内容,并以具有成本效益的方式或及时地 开发新节目;
     
  对于我们遵守联邦法律和规定、特别是90/10规则和群体违约率的能力存在不确定性;
     
  我们战略计划的成功实施;
     
  我们无法保持符合资格或处理联邦学生财政援助;
     
  针对我们或其他行业板块公司的监管调查或采取的行动;
     
 

行业板块中的规制环境变化或预算限制;

     
  招生人数下降;我们学生因经济环境而找不到工作的挑战;
     
  维护和扩展现有行业关系,并建立新的行业关系;
     
  我们高级管理层或其他关键员工的流失;
     
  新校区开放和现有校区关闭所带来的不确定性;
     
  收购学校整合相关的不确定性;
     
  行业板块竞争;
     
  任何网络安全概念事件的影响;
     
  一般经济条件。

 

所有板块的前瞻性陈述仅限于本第10-Q表格的提交日期。在每种情况下,实际结果可能与这些前瞻性资讯有所不同。我们不能保证这些期望或前瞻性陈述将被证明正确。在本第10-Q表格中提及的一个或多个风险因素或风险和不确定性发生或出现任何重大不利变化,或包含在我们的其他公开披露或其他定期报告或其他文件或提交给美国证券交易委员会(“SEC”)的文件可能会对我们的业务,前景,财务状况和经营成果产生重大不利影响。除非法律要求,否则我们不打算更新或修订任何此类前瞻性陈述,以反映实际结果,计划变更,假设,估计或投资组合的变化,或发生在本第10-Q提交日之后影响此类前瞻性陈述的其他情况,即使这些结果,变化或情况清楚表明任何前瞻性资讯也不会实现。我们在本第10-Q提交后公开的任何声明或披露,如果对本第10-Q中包含的任何前瞻性陈述进行修改或影响,将被视为修改或取代此类陈述在本第10-Q中的陈述。

 

本季度10-Q表格的内容可能包括市场数据和某些行业数据和预测,我们可能从内部公司调查、市场调研、顾问调查、公开可得信息、政府机构的报告和行业出版物、文章和调查中获得。行业调查、出版物、顾问调查和预测通常声明所包含的信息来源认为是可靠的,但不保证此类信息的准确性和完整性。虽然我们相信这样的研究和出版物是可靠的,但我们没有独立验证来自第三方来源的市场和行业数据。

 

ii

 

 

第一部分 - 财务信息

 

项目 1. 基本报表。

 

传承 教育公司。

(以High Desert Medical College为名

(营业名称 中央海岸学院)

(Integrity College of Health简称ICoH)

截至2024年及2023年9月30日的合并 基本报表

 

目 录

 

  页面
   
基本报表: F-1
   
合并资产负债表 F-2
   
合并利润表 F-3
   
合并股东权益表 F-4
   
合并现金流量表 F-5
   
合并财务报表附注 F-6 到 F-20

 

F-1

 

 

Legacy 教育公司

合并资产负债表

 

   2024年9月30日
(未经审计)
   2024年6月30日 * 
         
资产          
流动资产合计          
现金及现金等价物  $21,492,618   $10,376,149 
应收帐款,净额为$1,245,164688,848 截至2024年9月30日及2024年6月30日的呆帐拨备   12,255,677    13,038,241 
预付费用   963,503    1,032,325 
其他应收款   140,894    140,894 
流动资产总额   34,852,692    24,587,609 
           
不动产及设备,净额   1,185,160    989,952 
经营租赁权使用资产   8,370,928    3,575,369 
融资租赁使用权资产   340,048    340,048 
无形资产   1,053,694    1,054,947 
商誉   1,929,326    1,929,326 
应收账款,长期   1,525,250    1,381,194 
透过权益法之投资   898,000    898,000 
保证金   425,769    416,605 
总资产  $50,580,867   $35,173,050 
           
负债及股东权益          
流动负债          
应付帐款及应计负债  $4,353,836   $3,862,895 
应计所得税负债   295,711    1,443,335 
递延、未赚取的学费   3,792,429    2,585,747 
其他流动负债   39,737    24,201 
当前偿还部分债务   569,002    574,244 
应付的债务,与相关方   50,000    50,000 
融资租赁的当前部分   58,887    57,260 
营业租赁负债流动部分   2,190,714    1,868,560 
流动负债总额   11,350,316    10,466,242 
           
债务,未来部份   139,170    123,862 
融资租赁,扣除当前部分   139,346    215,409 
其他负债   89    905 
租赁负债净额,除去当期部分   6,396,058    1,947,620 
总负债   18,024,979    12,754,038 
           
合约和可能负债   -    - 
           
股东权益          
优先股:$0.001 面值, 10,000,000 授权的股份; no 已发行并流通股份   -    - 
采纳新会计准则0.001 面值, 100,000,000 授权股份数, 11,867,1499,291,149 于2024年9月30日和2024年6月30日分别公布及未公布的股份。   11,867    9,291 
额外资本赠与金   24,229,798    16,186,251 
保留盈余   8,314,223    6,223,470 
股东权益总额   32,555,888    22,419,012 
负债和股东权益总额  $50,580,867   $35,173,050 

 

*来源于经过审计的资讯

 

附注是这些未经审计的合并财务报表的一个组成部分。

 

F-2

 

 

遗产 教育股份有限公司

综合 收益表

截至2024年9月30日及2023年9月30日的三个月

(未经审计)

 

   2024   2023 
  

截至三个月结束

九月三十日,

 
   2024   2023 
营业收入          
学费及相关收入,净额  $14,005,091   $10,366,934 
           
营运费用          
教育服务   7,204,574    5,732,126 
一般及行政费用   3,966,047    3,154,405 
一般及行政 - 关联方   81,053    42,000 
折旧及摊销   81,141    57,859 
总成本和开支   11,332,815    8,986,390 
           
营业收入   2,672,276    1,380,544 
           
其他收入(费用)          
利息支出   (29,350)   (28,266)
利息收入   260,896    143,134 
其他收益合计   231,546    114,868 
           
税前收入   2,903,822    1,495,412 
所得税费用   (813,069)   (425,816)
净利润  $2,090,753   $1,069,596 
           
每股净利润          
基本每股盈利  $0.22   $0.12 
每股稀释后的净利润  $0.21   $0.11 
           
加权平均普通股持有量          
基本加权平均流通股数   9,320,063    9,291,149 
稀释加权平均股数   9,817,558    9,691,149 

 

附注是这些未经审计的合并财务报表的一个组成部分。

 

F-3

 

 

传承 教育公司。

合并 股东权益变动表

截至2024年和2023年9月30日三个月的财务状况

(未经审计)

 

   股份   金额   股份   金额   资本   盈余   总计 
   优先股   普通股  

追加

支付

   保留     
   股份   金额   股份   金额   资本   盈余   总计 
2024年6月30日资产负债表        -   $    -    9,291,149   $9,291   $16,186,251   $6,223,470   $22,419,012 
                                    
行使期权   -    -    76,000    76    39,444    -    39,520 
普通股发行,扣除发行成本后的净利润   -    -    2,500,000    2,500    7,937,072    -    7,939,572 
基于股票的薪酬   -    -    -    -    67,031    -    67,031 
净利润   -    -    -    -    -    2,090,753    2,090,753 
截至2024年9月30日的余额   -   $-    11,867,149   $11,867   $24,229,798   $8,314,223   $32,555,888 

 

   优先股   普通股  

额外

已付款

   保留     
   股票   金额   股票   金额   首都   收入   总计 
二零二三年六月三十日余额        -   $     -    9,291,149   $9,291   $14,304,175   $1,108,618   $15,422,084 
净收入   -    -    -    -    -    1,069,596    1,069,596 
二零二三年九月三十日结余   -   $-    9,291,149   $9,291   $14,304,175   $2,178,214   $16,491,680 

 

附注是这些未经审计的合并财务报表的一个组成部分。

 

F-4

 

 

传承 教育公司。

综合现金流量表

截至2024年和2023年9月30日三个月的财务状况

(未经审计)

 

   2024   2023 
   截至三个月结束
九月30日,
 
   2024   2023 
营业活动提供的(使用的)现金流量:          
净利润  $2,090,753   $1,069,596 
调整后的净损益:          
非现金补偿   67,031    - 
折旧及摊提   81,137    57,859 
递延所得税   -    - 
应收账款及合同应收账款的呆账准备   556,316    442,641 
资产及负债的变动:          
应收账款   82,193    (1,953,326)
预付费用   (208,042)   (208,700)
其他应收款   -    - 
关系方应收款项   -    - 
其他资产   (34,133)   41,805 
应付帐款及应计负债   490,941    186,428 
应付所得税   (1,147,624)   647,131 
递延未赚取学费   1,206,682    201,183 
经营活动产生的净现金流量   3,185,254    484,617 
           
投资活动中使用的现金流量:          
购置财产及设备   (235,816)   (177,392)
投资活动中使用的净现金   (235,816)   (177,392)
           
来自筹资活动的现金流量:          
首次公开募股的收益,扣除发行成本   8,216,438    - 
期权行使所得款项   39,520    - 
融资租赁的本金支付   (56,184)   (54,614)
偿还债务的本金支付   (32,743)   (151,110)
融资活动提供的(使用的)净现金   8,167,031    (205,724)
           
现金及现金等价物及受限现金的净增长   11,116,469    101,501 
年初的现金及现金等价物及受限现金   10,376,149    9,389,606 
年末的现金及现金等价物及受限现金  $21,492,618   $9,491,107 
           
现金流额外披露         
期间内支付的利息现金  $24,052  $27,602
所得税现金支付期间  $1,960,693   $- 
           
非现金活动的补充披露          
非现金购买融资租赁资产  $-   $340,048 
非现金购买设备  $39,275   $34,580 
预付费用重新分类为发行成本  $276,866   $- 

 

附注是这些未经审计的合并财务报表的一个组成部分。

 

F-5

 

 

传承 教育公司。

合并基本报表注解

截至2024年和2023年9月30日三个月结束

(未经审计)

 

注意 1 - 业务性质

 

用于 这些财务报表的目的,「遗产」,「公司」,「我们」,「我们」,「我们」 或类似的参考是指旧式教育有限公司及其合并子公司,除非上下文另有规定。遗产 教育有限责任公司于 2009 年 10 月 19 日在加利福尼亚州成立,是一家有限责任公司。本公司以职业生涯发展 通过在不同的就业市场中利用教育实践来专注于实际培训的机构。本公司提供计划 在医疗保健,兽医,医疗信息技术,业务管理和绿色技术等职业途径。公司 获得持续教育和培训认可委员会(「ACCET」)和卫生认可局认可 教育学校(「ABHES」),并获得私立专上教育局批准在加利福尼亚州运营 (「贝普」)。合并财务报表包括传承教育公司 d/b/a 高沙漠医学院的帐目 (「HDMC」)及其全资子公司传承教育蒙特利有限公司(「蒙特利」)d/b/a 中央海岸学院 (「CCC」)及其全资子公司先进健康服务有限责任公司 d/b/a 诚信健康学院(「诚信」)。 根据合并及重组协议及计划(「重组合并」),于 2021 年 9 月 1 日生效 截至 2021 年 9 月 3 日(「生效日期」),传承教育合并子公司,传统教育全资附属公司 Inc. 仅为实施重组合并而成立,与传统教育有限责任公司合并并与传统教育有限责任公司合并 教育有限责任公司在合并后生存并成为传奇教育公司的全资子公司,该公司于 3 月 18 日成立, 2020 年在内华达州,唯一目的是将公司从成员拥有的有限责任公司重组为 股东拥有的 C 股份有限公司。 在生效日期,以换取旧式教育有限责任公司拥有的每个 A 类单位,成员 传承教育有限责任公司获得传承教育有限公司的一股普通股份,以一为一交易所。立即会员 在重组之前,合并成为 100重组合并后立即传统教育有限公司拥有人百分比。

 

HDMC提供二十九个课程,包括超声波技师、超声波技师应用科学学位、医疗帐务与编码、职业护理、临床医务助理、药剂助理、牙科助理、医务行政、职业护理应用科学学位和注册护理。

 

CCC,HDMC的全资附属公司,提供医疗职业培训课程和兽医职业培训。

 

Integrity, HDMC的全资子公司,是一所经认证的学院,提供医疗助理、职业护理、医疗保险编码和结算、诊断医学超声波(超声技师)以及护理学理学士学位(从注册护士到护理学士)的教学。

 

随附的合并基本报表和本文件中包含的所有每股资讯已被进行过去式调整,以反映附录12中描述的股票逆向合并。

 

备注 2 - 重要会计原则摘要

 

合并的主要原则

 

合并基本报表包括HDMC及其全资子公司CCC和Integrity的账户。所有重大关联方余额和交易在合并中已被消除。

 

基础 陈述 未经审计的中期财务信息

 

附表的中期汇编未经审计。管理层认为,附表的未经审计的汇编基本报表包含所有必要的正常循环调整,能够公正地展示所述期间的财务状况和运营结果。中期结果未必反映全年或未来期间的预期结果。

 

根据美国通用会计准则编制的合并基本报表通常包括在根据美国证券交易委员会(“SEC”)规则和法规简化或省略的特定信息和脚注披露。公司认为,这些披露足以使中期信息呈现不具误导性。这些合并基本报表应与公司报告于2024年10月1日提交的10k表格中包含的审计后合并基本报表和附注一起阅读,截至2024年6月30日的年度。

 

使用估计值

 

根据美国公认会计准则(“GAAP”)编制财务报表需要管理层进行估计和假设,这些估计和假设将影响资产和负债的报告金额以及在财务报表日期和报告期间内收入和费用的报告金额披露。实际结果可能会与这些估计有所不同。受此类估计和假设影响的重要事项包括用于评估公司的独立履行义务的假设,以及权益工具的估值和与应收账款相关的信贷损失准备。

 

F-6

 

 

重新分类

 

过去期间基本报表中的某些金额已重新分类以符合当前期间的呈现方式。这些重新分类对报告的合并净利润没有任何影响。

 

现金及现金等价物

 

公司认为所有购买期限三个月或更短的高流动性工具都应视为现金等价物。这些投资按成本列示,接近公允价值。

 

固定资产

 

物业 和设备以成本减去累计折旧的方式进行记录。折旧采用直线法计算。正常的维修 和保养费用在发生时计入费用。对资产的重大支出则资本化。折旧 是通过直线法根据资产的预计使用寿命进行的。家具和固定装置、机械、计算机 设备和车辆的预计使用寿命一般为 , , ,和 五年,分别。租赁改进 则在租期或其使用寿命较短的一方进行折旧。

 

租赁

 

在 2016年2月,FASB发布了ASU 2016-02,租赁(主题842),旨在通过在资产负债表上确认租赁资产和租赁负债,提高组织之间的透明度和可比性,针对那些在当前GAAP下被归类为经营租赁的租赁。ASU 2016-02要求承租人应在资产负债表上确认租赁付款的负债(租赁负债)和代表其在租赁期限内使用基础资产权利的使用权资产。ASU 2016-02适用于2021年12月15日后开始的财政年度,采用修订后的追溯方法,并允许提前采用。公司于2022年7月1日采用了ASU 2016-02。

 

公司已选择在租赁开始时适用为期12个月或更短的短期范围例外,并将继续按直线法确认租金费用。 因此,2022年7月1日,公司承认了大约$5.7 百万,这代表了使用估计增量借款利率的剩余最低租赁付款的现值为 3.98%. 截至2022年7月1日,公司确认了一项大约$5.3百万的使用权资产。由于采用ASU 2016-02,租赁费用没有实质性变化。

 

商誉 和无形资产

 

商誉 代表2019年12月和2019年1月15日收购的净资产(包括无形资产)的购买价格超过公平市场价值。公司已实施了《财务会计准则委员会》(“FASB”)会计准则法规(“ASC”)350的业务合并主题。 无形资产 - 商誉和其他。

 

商誉、商标和认可被视为具有无限的使用寿命,课程大纲的使用寿命大约为 年。 18 商誉和无限使用寿命的无形资产不进行摊销,但至少每年进行一次减值测试。公司将维持或扩展无形资产的费用在发生时计入支出。

 

公司对无形资产(有确定使用寿命)、不包括商誉、认证和商标,在事件或情况变化表明资产账面价值可能无法收回时进行减值评估。我们通过比较资产的账面价值与预期能够产生的未折现未来现金流量来衡量这些资产的可回收性。如果资产的账面价值无法收回,那么确认的减值额度就是资产账面价值超过其公允价值的金额。有 没有 按照所呈现期间进行的减值。

 

F-7

 

 

公司至少每年对商誉、认证和交易名称进行减值测试,或在事件或情况变化表明资产可能减值时更频繁地进行测试。 没有 在所呈现的期间内没有商誉、认证或交易名称的减值。

 

公司对具有确定用途的无形资产采用直线法进行摊销。

 

长期资产

 

公司在事件或情况发生变化时,会评估其长期资产的可收回性以确定是否存在减值的情况,除商誉之外。要持用资产的可收回性是通过比较资产的账面价值与预计资产产生的未打折未来净现金流量来衡量的。如果这些资产被认为减值,那么将确认的减值金额将是资产的账面价值超过资产公允价值的部分。公允价值估计是基于对未来现金流量金额和时间的假设。截至2024年9月30日和2024年6月30日,公司已经发生了长期资产减值。 没有 分别是2024年9月30日和2024年6月30日,公司发生了长期资产减值。

 

营业收入 确认

 

当公司将承诺的货物或服务的控制权转移给客户,并且预期获得的代价相应地为那些货物或服务时,营业收入被确认。公司根据ASC 606执行五步方法来判断营业收入:(i) 辨认与客户的合同,(ii) 确认合同中的履约义务,(iii) 确定交易价格,(iv) 将交易价格分配给合同中的履约义务,以及 (v) 在公司满足履约义务时(或之后)确认收入。

 

公司在确认营业收入时识别合同,当双方都有批准和承诺,双方的权利和付款条款明确,合同具有商业实质,并且预期收益可收回时。公司评估每份合同以判断合同中独立的履约义务的数量,这需要使用判断。公司的合同包括教育服务和课程材料的承诺,这些都是独立的履约义务。

 

学费 营业收入主要来源于提供给学生的高等教育服务。一般来说,学费和其他费用是提前支付的,并在教育服务提供给学生之前记录在合同负债中。对于未提前支付的学费部分,会记录学费应收款。在某些情况下,提供给学生分期账单的选项,这减少了在提供服务之前收到的现金款项。与分期账单相关的合同条款和条件表明,学生对合同总价负责,因此减少了公司因未付款而面临的损失风险。学费营业收入在授课期间按比例确认。公司通常使用经过的时间法,这是一种投入测量,因为它最能反映学费服务的同时消费与交付。与特定课程材料相关的营业收入在控制权转移给学生的时点确认,通常是在材料交付给学生时。与实验室服务相关的营业收入在服务提供的时间段内确认。

 

公司的退款政策可能允许未完成课程的学生有资格获得未参加课程部分的退款。退款通常会导致学生退课或退出课程期间的递延营业收入减少。

 

交易价格在合同中被明确规定并在合同成立时已知,因此根据公司的退款政策,当学生根据公司的退款政策退出课程或者如果学生需要额外时间完成课程至合同结束日期之后,将会有变动的考量。公司认为在这些情况下的经验对未来学生的表现几乎没有预测价值,因为学生的未来表现取决于个人情况,变动考量的金额受到公司影响范围之外因素的高度影响。因此,在消除限制之前,交易价格中并未包括任何变动考量,且未将其认定为收入。营业收入根据其独立销售价格分配给每个履行义务。合同内的任何折扣都会分配给所有履行义务,除非有可观察的证据表明该折扣与合同中特定履行义务或履行义务有关。公司通常根据向学生收取的价格来确定独立销售价格。

 

F-8

 

 

公司从营业收入中排除由政府机构征收的税款,因为这些是代表他们从客户收取的代理交易。重要的判断包括合约价格在履约义务之间的分配、在教学期间按比例获得学费的方式、交易价格中包含的变量考量金额的估算,以及确定影响变量考量未能在营业收入中确认的约束的影响。

 

营业收入的分解

 

直觉和相关的营业收入在截至2024年9月30日及2023年9月30日的三个月期间包含以下内容:

 

   2024   2023 
学费和实验室费用(按时间分期认列)  $12,120,857   9,921,049
书籍、注册费和其他费用(在某一时间点认列)   1,884,234    445,885 
总营业收入  $14,005,091   $10,366,934 

 

信贷损失准备

 

公司记录账户应付坏帐的估计亏损,这些亏损是由于学生未能、未能或拒绝进行付款所致,其中包括先进给学生的金融援助资金超出学生学费及相关费用的部分。公司根据对历史呆账经验、当前经济趋势以及应收账款和学生状况的分析,判断其令人怀疑的账户拨备的足够性。公司根据应收账款和学生状况所呈现的风险估计,对其应收账款适用拨备。公司在早于账户余额被视为无法收回的时间或在收入生成后一年之前,将不活跃学生的账户余额账清。坏呆账费用记录在附属的损益表中作为总务及管理费用。公司每年进行分析,以确定哪些账户无法收回,然后进行账清。

 

退款

 

公司在学生取消或退学后45天内支付或记入退款给那些已完成的学生, 60%或以下的出勤时间根据比例计算。一旦学生完成超过 60%的出勤时间,所有Title IV所需的所有基金类型都被视为已赚取,且不需退款给教育部。

 

广告

 

公司将广告费用视为发生时即成本。广告费用分别为$1,166,8981,093,784分别为截至2024年和2023年9月30日结束的三个月。

 

按股份分享计划支付的报酬

 

该 公司根据ASC 718, 股票补偿, 涉及基于股份的支付的会计处理,因此,根据对期权及限制股票奖励的授予日期公允价值的评估,记录基于股份的奖励的薪酬费用。该 公司根据期权定价模型在授予日期估算基于股份的薪酬奖励的公允价值。根据预期最终可归属于奖励的部分,成本在公司的综合损益表中按所需服务期间确认为费用。该公司使用Black-Scholes模型来估算基于股份的薪酬奖励的公允价值。该模型要求公司估计其普通股的预期波动性和价值,以及期权的预期期限,这些都是非常复杂和主观的变数。预期寿命是根据美国证券交易委员会(SEC)工作会计公报第110号《按股份支付》所述的简化方法计算的。该公司的预期波动性的估算是基于同行的波动性。该公司根据与预期期权期限相当的美国国债的隐含收益率选择了一个无风险利率。该公司在发生时对丧失进行会计处理。

 

F-9

 

 

金融工具公允价值

 

本 公司的金融工具主要包括现金及现金等价物、应收账款、应付账款及应计负债、递延及未赚取学费、债务及融资租赁义务。公司的金融工具的帐面价值大致等于公允价值。

 

FASB ASC 820, Fair Value Measurements (“ASC 820”)建立了所有公允价值测量的框架,并扩展公允价值测量和发展相关的披露。ASC 820将公允价值定义为在测量日期,市场参与者之间按照秩序进行的交易中将获得的销售资产的价格或转移负债所支付的价格。

 

ASC 820要求按公允价值计量的资产和负债被分类并披露在以下三个类别之一:

 

层级 1在活跃市场或可观察的输入中,相同资产或负债的报价市场价格;

等级 2可以由可观察市场数据予以证实的重要其他可观察输入;以及

等级 3无法透过可观察市场数据进行证实的重要不可观察输入。

 

信用风险的集中度

 

截至2024年6月30日及2023年6月30日,收入的相当大部分及应收账款的结束,直接源于本公司参与的财政学生援助("FSA")计划,这是学生学费的主要来源。FSA计划受政治预算考量的影响。无法保证资金会维持在当前水平。FSA计划受到重大的监管要求约束。任何监管违规都可能对公司产生重大影响。

 

公司在不同的金融机构中维持其现金及现金等价物。这些机构的账户由联邦存款保险公司保险,最高可达$250,000公司定期评估这些机构,以限制集中风险的暴露。公司不时在这些限制之上维持现金余额。

 

截至2024年9月30日及2024年6月30日,$2.182.15 百万,分别维持在可赎回的货币市场账户中,轴承的利息约为 4.88每年%的利率。

 

承诺事项和或有事项

 

当公司预期可能已产生负债且该金额可以合理估计时,将就或有负债进行累计。 当公司知道有索赔或潜在索赔时,会评估任何损失风险的可能性。如果损失很可能发生且损失的金额可估算,公司将为预估的损失记录负债。如果损失不太可能发生,或者潜在损失的金额不可估算,公司将在潜在损失的可能性合理的情况下披露该索赔,并且潜在损失的金额可能会是重要的。对未来变化特别敏感的估算包括税务、法律及其他监管事宜,这些事宜可能会随著事件的发展及在行政和诉讼过程中获得的更多信息而改变。公司将合法费用视为发生时的支出。

 

收入 税收

 

GAAP 要求管理层评估公司采取的税务立场,并在公司采取的立场存在不确定性且较可能在国税局的检查中得到支持时认列税务负债。管理层已分析公司的税务立场,并认为没有不确定的立场被采取或预期将被采取,因此不需要在财务报表中认列负债或披露。

 

F-10

 

 

公司财务报表中,针对本年度应付或可退还的所得税,以及未来因已在公司基本报表或税务申报表中确认的事件而产生的递延税资产和负债进行会计处理。递延税资产和负债是根据预期实现的年度适用的税率来进行测量。

 

公司对应的联邦及州所得税的罚款和利息,于产生时列作费用。如有罚款,则包含在损益表上的一般及管理费用中。估计的联邦和州有效税率为 21%及 8.84,分别为%。

 

Emerging Growth Company

 

The Company has elected to be an emerging growth company as defined under the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”). Included with this election, the Company has also elected to use the provisions within the JOBS Act that allow companies that go public to continue to use the private company adoption date rules for new accounting policies. The Company will remain an emerging growth company until the earlier of (i) the last day of the Company’s fiscal year following the fifth anniversary of the closing of the Company’s initial public offering of its securities, (ii) the last day of the fiscal year (a) in which the Company total annual gross revenue of at least $1.235 billion or (b) in which the Company is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission, and (iii) the date on which the Company has issued more than $1.0 billion of non-convertible debt in any three-year period.

 

Earnings Per Share

 

ASC 260, Earnings Per Share, requires dual presentation of basic and diluted earnings per share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution. Diluted EPS is calculated using the treasury stock method, and reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.

 

The following table provides a reconciliation of the numerators and denominators used to determine basic and diluted net income per common share for the three months ended September 30, 2024 and 2023:

 

   2024   2023 
Numerator          
Net income  $2,090,753   $1,069,596 
           
Denominator          
Weighted-average shares outstanding, basic   9,320,063    9,291,149 
Dilutive impact of share-based instruments   497,495    400,000 
Weighted-average shares outstanding, diluted   9,817,558    9,691,149 
           
Net income per share          
Basic  $0.22   $0.12 
Diluted  $0.21   $0.11 

 

F-11

 

 

Recent Accounting Pronouncements

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 provides guidance for recognizing credit losses on financial instruments based on an estimate of current expected credit losses model. The amendments are effective for fiscal years beginning after December 15, 2019. Recently, the FASB issued the final ASU to delay adoption for smaller reporting companies for fiscal years beginning after December 15, 2022. We adopted ASU 2016-13 on July 1, 2023 and it did not have a material impact on our consolidated financial statements and related disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity’s own equity, and also improves and amends the related earnings per share guidance for both Subtopics. The ASU will be effective for smaller reporting companies for annual reporting periods beginning after December 15, 2023 and interim periods within those annual periods and early adoption is permitted. We adopted ASU 2020-06 on July 1, 2024 and it did not have a material impact on our consolidated financial statements and related disclosures.

 

Note 3 - Intangible Assets

 

The intangibles consisted of the following as of September 30, 2024 and June 30, 2024:

 

   September 30, 2024   June 30, 2024 
Goodwill  $1,929,326   $1,929,326 
Trade name   796,100    796,100 
Accreditation   88,200    88,200 
Course curriculum   198,000    198,000 
Total cost of intangibles  $3,011,626   $3,011,626 
Less accumulated amortization   (28,606)   (27,353)
Intangibles net  $2,983,020   $2,984,273 

 

截至2024年9月30日和2024年6月30日, 没有 与其对CCC和Integrity的先前收购有关,公司不会需要对其商誉或其他无形资产进行减值。 虽然ACCEt认证是无限期的,但该认证每五年需要更新。CCC的ACCEt认证最近一次是在2020年4月续签,下一次续签是在2025年4月。 公司在2024年9月30日结束的三个月和九个月内,在综合损益表的其他综合损失中承认了$1,253 截至2024年和2023年9月30日的三个月的摊销费用。虽然健康教育学校认证局(“ABHES”)具有无限期的生命周期,但该认证每五年需要更新。Integrity的下一次ABHES认证续签是在2026年2月28日。 100预计% 的商誉可以在联邦所得税上扣除,并将在 15 按直线法计算的年限。

 

注 4 - 资产和设备

 

资产和设备包括以下内容:

 

   2024年9月30日   2024年6月30日 
租赁改良  $678,078   $561,108 
机械和设备   1,043,700    1,032,286 
计算机设备   848,616    704,846 
家具、装置和其他设备   269,860    266,923 
家具、固定资产和其他设备 [会员]          
总计   2,840,254    2,565,163 
减:累计折旧和摊销   (1,655,094)   (1,575,211)
物业和设备,净值  $1,185,160   $989,952 

 

与财产和设备相关的折旧 和摊销费用总计 $79,883 and $56,606 截至2024年和2023年9月30日的三个月。

 

F-12

 

 

注5 - 应收账款,开多期

 

学费灵活支付

 

TuitionFlex计划旨在为学生和家庭创建灵活的学费信贷计划,以帮助弥合财务差距,所有板块均符合适用的联邦真实借贷法规。通过该计划,我们为所有学生提供最多5年的付款计划,无论其财务需求如何。使用Tuition Flex计划的学生应收账款的长期部分为$1,525,250 and $1,381,194 截至2024年9月30日和2024年6月30日分别。

 

第6注 - 其他预付费用

 

截至2024年9月30日和2024年6月30日,预付费用包括以下内容:

 

   2024年9月30日   2024年6月30日 
图书  $229,549   $199,122 
物资和其他预付费用   733,954    833,203 
预付款  $963,503   $1,032,325 

 

注7 - 公司授权发行其他应收款

 

截至2024年9月30日和2024年6月30日,其他应收款包括以下内容:

 

   2024年9月30日   2024年6月30日 
其他方式   94,454    94,454 
员工留任税收抵免   46,440    46,440 
其他应收账款总额  $140,894   $140,894 

 

公司代表一位外国投资者支付了联邦所得税106,846 遗产中,公司应返还的金额为$94,454截至2024年9月30日和2024年6月30日。

 

在截至2021年6月30日的财政年度, 公司根据《CARES法案》申请了约$的员工保留信用(“ERTC”)。2.9 截至2024年9月30日和2024年6月30日, ERTC应收款的余额为$。46,440.

 

提示 8 - 应付账款及应计费用

 

截至2024年9月30日和20234年6月30日的应付账款和应计费用如下:

 

   2024年9月30日   2024年6月30日 
应付账款  $1,669,932   $1,532,576 
应计工资和工资税   389,813    641,594 
应计假期   445,434    447,482 
应计奖金   1,795,113    1,200,000 
应计其他费用   53,544    41,243 
总计  $4,353,836   $3,862,895 

 

F-13

 

 

注9 - 债务和其他负债

 

(1) 应付票据 记事

 

公司从几个债权人那里收到了$750,000 的款项,其中包括来自关联方的$150,000 根据无担保本票,本金应在以下较早的日期到期并应付清:(i)根据每份本票首次支付之日起的9个月纪念日;或(ii)受益方(“到期日”)首次公开募股的完成日期,并且本票应按照按未偿金额所据任何计算日的月利率 1%支付利息,利息应在首次支付资金之日后的每个月的第15日起按月支付。这些本票的到期日已延长至 2021年3月31日。债权人同意推迟偿还本金余额,直到未来首次公开募股完成。

 

   2024年9月30日   2024年6月30日 
签发的期票于 2019年11月12日  $500,000   $500,000 
签发的期票于 2019年12月30日,相关方   50,000    50,000 
所有基金类型债务总额  $550,000   $550,000 

 

另有一份于2020年2月6日发行的注释已于2023年9月以现金偿还。 2020年2月6日发行的另一份注释已于2023年9月以现金偿还。$100,000 2020年2月6日发行的另一注释已于2023年9月以现金偿还。

 

(2) 设备 借款

 

2023年1月,公司签订了一项设备贷款,金额为$30,744。该票据的利息按照 6.0%的年利率计息,并要求48 平均每月付款。截至2024年9月30日和2024年6月30日,本票据的本金余额为$19,005 and $20,929有效所得税率为

 

在2023年8月,公司签订了一份设备贷款,金额为$35,580。该票据的利息按每年 10.14%的利率累积,并要求48 等额的月供支付。截至2024年9月30日和2024年6月30日,票据的本金余额为$25,789 and $27,723有效所得税率为

 

2023年11月,公司签订了一项设备贷款,金额为$14,610。该票据按年利率 10.72%计息,要求48 等额月付。截至2024年9月30日和2024年6月30日,本票据的本金余额为$11,788 and $12,582有效所得税率为

 

在 2023年12月,公司签订了一项设备贷款,金额为$11,920。该票据的利率为 13.53%每年,并要求 36 相等的每月还款。截至2024年9月30日和2024年6月30日,备用票据的本金余额为$8,978 and $9,853有效所得税率为

 

在 2024年2月,公司签署了一项设备贷款,金额为$35,612。该票据按利率 8% 每年计息,并要求 36 等额月供。首期付款将在2024年4月1日进行。截至2024年9月30日和2024年6月30日,票据的本金余额为$30249 and $32,950,分别。

 

2024年6月,公司签订了一份设备借款协议,金额为$48,966。该票据年息率为 11.16%,并需要48 等额月付款。首笔付款将于2024年6月1日支付。截至2024年9月30日和2024年6月30日,本票据的本金余额为$45,650 and $48,125,分别。

 

2024年7月,公司为购买设备签订了一份贷款合同,金额为$39,189。该票据按照每年 11.15%的年利率计算利息,需要48 等额月付。第一笔付款将于2024年7月1日支付。截至2024年9月30日和2024年6月30日,该本票据的本金余额为$45,650 and $0,分别。

 

F-14

 

 

(3) 银行 贷款

 

On December 31, 2019, the Company acquired Integrity, assuming its two bank loans, which are secured by all business assets of the Company.

 

   September 30, 2024   June 30, 2024 
Bank loan #1, monthly payment $803.69, due in 110 months, effective interest rate 6.44%  $22,805   $24,447 
Bank loan #2, monthly payment $5,672.86 start on November 23, 2020, due in 48 months   6,699    21,495 
Total bank loans  $29,504   $45,942 

 

Future maturities over the remaining term of total debt for (1) to (3) are as follows:

 

      
2025 (1)  $603,366 
2026   67,118 
2027   60,664 
2028   27,024 
Long-term debt   758,172 
Less: current portion (1)   (619,002)
Long-term portion of debt  $139,170 

 

(1) Includes $50,000 related party debt

 

Note 10 - Related Party Transactions

 

A shareholder of the Company was paid $22,500 as consulting fees in the three months ended September 30, 2024 and 2023.

 

A director of the Company was paid $19,500 in consulting fees in the three months ended September 30, 2024 and 2023.

 

A director of the Company was paid $39,053 and $25,950, respectively, in the three months ended September 30, 2024 and 2023 as consulting fees.

 

In December 2019, the Company received $50,000 of proceeds from a promissory note, entered into with an executive of the Company, which bears interest at the rate of 12% per annum and matures on the earlier of the nine-month anniversary of the loan or the completion of an initial public offering. The balance of this note was $50,000 as of September 30, 2024 and June 30, 2024.

 

Note 11 – Lease Commitments

 

Finance Leases

 

In July 2023, the Company entered into an equipment lease for $340,048. The related finance liability has an implied interest rate of 11.16% per annum and requires 5 equal annually payments on September 1, 2023. As of September 30, 2024 and June 30, 2024, the balance of the finance liability was $198,233 and $272,669, respectively.

 

The present value of future minimum lease payments due at September 30, 2024, was as follows:

 

      
2025   - 
2026   81,459 
2027   81,459 
Thereafter   81,458 
Total minimum payments   244,377 
Less: amount representing interest   (46,144)
Present value of minimum payments  $198,233 
Less: current portion   (58,887)
Long term portion  $139,346 

 

F-15

 

 

Operating Leases

 

The Company leases its instructional facilities under non-cancelable operating leases expiring at various dates through 2026. In most cases, the facility leases require the Company to pay various operating expenses of the facilities in addition to base monthly lease payments. In certain cases, the Company has options available under its leases to renew, and certain leases contain ordinary rental escalations on the space. Rent expense for the certain leases described above is recorded evenly over each lease term. The difference between rent expense recorded and the amount paid is reflected as deferred rent on the accompanying balance sheets for those leases with rent escalation clauses.

 

Because the rate implicit in each lease is not readily determinable, the Company uses its incremental borrowing rate to determine the present value of the lease payments. The Company has elected the practical expedient to use the risk-free rate as its incremental borrowing rate.

 

June 30, 2024 are as follows:

 

      
2025  $1,786,450 
2026   2,084,138 
2027   1,155,836 
2028   830,612 
2029   847,224 
After 2029   2,719,747 
Total future minimum operating lease payments   9,424,007 
Less: imputed interest   (837,235)
Total   8,586,772 
Current portion of operating lease   2,190,714 
Long term portion of operating lease  $6,396,058 

 

Total rent expense and related taxes and operating expenses under operating leases for the three months ended September 30, 2024 and 2023 were $999,115 and $867,624, respectively.

 

Supplemental balance sheet information related to leases was as follows:

 

   September 30, 2024   June 30, 2024 
         
Operating lease right-of-use assets  $8,370,928   $3,575,369 
           
Operating lease liability - current  $2,190,714   $1,868,560 
Operating lease liability – non-current   6,396,058    1,947,620 
Total operating lease liability  $8,586,772   $3,816,180 

 

Other supplemental information:

 

   2024   2023 
   For the three months ended September 30, 
   2024   2023 
Cash paid for operating lease  $782,273   $543,993 

 

F-16

 

 

Note 12 – Stockholders’ Equity

 

Reverse Stock Split

 

On September 9, 2024, our stockholders approved an amendment to our articles of incorporation to effect a 1-for-2 reverse split of our common stock. The amendment to our certificate of incorporation was filed with the Nevada Secretary of State on September 9, 2024. The consolidated financial statements, and all share and per share information contained herein, have been retroactively adjusted to reflect the reverse stock split.

 

As of September 30, 2024 and June 30, 2024, the Company had 110,000,000 shares of authorized capital, par value $0.001, of which 100,000,000 shares are designated as common stock, and 10,000,000 shares are designated as preferred stock, which have liquidation preference over the common stock and are non-voting.

 

Equity Transactions

 

On September 27, 2024, the Company completed its initial public offering of 2,500,000 shares, priced at $4.00 per share.

 

No shares were issued during the three months ended September 30, 2023.

 

As of September 30, 2024 and June 30, 2024 the Company had 11,867,149 and 9,291,149 shares of common stock outstanding, respectively, and no shares of preferred stock issued and outstanding.

 

Note 13 - Share-Based Compensation Plans

 

Stock Options

 

The Company utilizes ASC 718, Stock Compensation, related to accounting for share-based payments and, accordingly, records compensation expense for share-based awards based upon an assessment of the grant date fair value for stock options and restricted stock awards. The Black Scholes option pricing model was used to estimate the fair value of the options granted. This option pricing model requires a number of assumptions, of which the most significant are: expected stock price volatility, the expected pre-vesting forfeiture rate, and the expected option term (the amount of time from the grant date until the options are exercised or expire). The Company estimated a volatility factor utilizing a weighted average of comparable published volatilities of its peers. The Company applied the simplified method to determine the expected term of stock-based compensation grants.

 

In prior years, the Company had granted time vested options to purchase shares of common stock with exercise prices ranging from $0.52 - $1.80 on the date of grant by the Board. These options vest ratably over a period of three years and expire ten years from the date of grant and the fair value of these options were calculated using the Black-Scholes Merton model. 

 

On April 1, 2024, the Company granted stock options to purchase an aggregate of 1,425,171 shares of its common stock at an exercise price of $3.74 per share to employees, directors, consultants and non-employee service providers pursuant to its 2021 Equity Incentive Plan.

 

In August 2024, 76,000 stock options were exercised at $0.52 per share of common stock.

 

On September 27, 2024, the Company granted stock options to purchase an aggregate of 250,000 shares of its common stock at an exercise price of $4.00 per share to employees, directors, consultants and non-employee service providers pursuant to its 2021 Equity Incentive Plan. These options vest ratably over a period of three years and expire ten years from the date of grant and the fair value of these options were calculated using the Black-Scholes-Merton model.

 

F-17

 

 

A summary of the activity related to stock option units granted is as follows:

 

       Summary of Stock Options
Outstanding
 
   Total
Options
  

Weighted
Average
Exercise
Price

per Option

  

Weighted
Average

Remaining
Contractual

Term (Years)

 
Outstanding as of June 30, 2024   1,825,171    3.26    8.30 
Granted   250,000    4.00    10 
Exercised   (76,000)   0.52    - 
Forfeited, canceled, or expired   -    -    - 
Outstanding as of September 30, 2024   1,999,171    3.46    8.60 
Exercisable as of September 30, 2024   1,384,466    3.28    8.10 

 

       Summary of Stock Options
Outstanding
 
   Total Options  

Weighted
Average

Exercise

Price

per Option

  

Weighted
Average

Remaining
Contractual

Term (Years)

 
Outstanding as of June 30, 2023   400,000    1.54    4.14 
Granted   -    -    - 
Exercised   -           
Forfeited, canceled, or expired   -           
Outstanding as of September 30, 2023   400,000    1.54    3.89 
Exercisable as of September, 2023   400,000    1.54    3.89 

 

A summary of the activity related to vested and unvested stock option units granted is as follows:

 

   Options
Outstanding
  

Weighted

Average

Exercise
Price

  

Weighted

Average
Grant Date
Fair Value

  

Average

Remaining

Contractual

Life (Years)

 
Balance – June 30, 2023, unvested   -   $-   $-    - 
Options issued   1,425,171    3.74    1.84    10.00 
Options vested   (987,534)   3.74    1.84    10.00 
Options expired   -    -    -    - 
Options exercised   -    -    -    - 
Balance – June 30, 2024, unvested   437,637   $3.74    1.84    9.75 
Options issued   250,000    4.00    1.94    10.00 
Options vested   (72,932)   3.74    1.84      
Options expired   -    -    -    - 
Options exercised   -    -    -    - 
Balance – September 30, 2024, unvested   614,705   $3.85   $1.88    9.71 

 

The Company valued options issued in April 2024 using the Black Scholes model utilizing volatility 45%, and a risk-free rate of 4.18%. The fair value of the options was $1.84 per option.

 

The Company valued options issued in September 2024 using the Black Scholes model utilizing volatility 45%, and a risk-free rate of 3.75%. The fair value of the options was $1.94 per option.

 

The Company recorded share-based compensation expense of $67,031 during the three months ended September 30, 2024, which is included in educational services. Unamortized compensation expense associated with unvested options is $1,154,314 and $737,333 as of September 30, 2024 and June 30, 2024, respectively. The weighted average period over which these costs are expected to be recognized is approximately 2.70 and 2.75 years.

 

F-18

 

 

Note 14 - Other Commitments and Contingency

 

Regulatory

 

In order for students to participate in Title IV federal financial aid programs, the Company is required to maintain certain standards of financial responsibility and administrative capability. In addition, the Company is accredited with ACCET and ABHES and approved by other agencies and must comply with rules and regulations of the accrediting body. As a result, the Company may be subject from time to time to audits, investigations, claims of noncompliance or lawsuits by governmental agencies, regulatory bodies, or third parties. While there can be no assurance that such matters will not occur and if they do occur will not have a material adverse effect on these financial statements, management believes that the Company has complied in all material respects with all regulatory requirements as of the date of the financial statements.

 

The Company is subject to extensive regulation by federal and state governmental agencies and accrediting bodies. In particular, the Higher Education Act of 1965, as amended (the “Higher Education Act”), and the regulations promulgated thereunder by ED, subject the Company to significant regulatory scrutiny on the basis of numerous standards that schools must satisfy in order to participate in the various federal student financial assistance programs under Title IV of the Higher Education Act.

 

Composite Score

 

As described above, ED requires institutions to meet standards of financial responsibility. ED deems an institution financially responsible when the composite score is at least 1.5. The Company’s composite score was 3.0 for the fiscal year ended June 30, 2023. The Company’s composite score calculation for the fiscal year ended June 30, 2024 has not been completed as of the date of these financial statements and is due on December 31, 2024.

 

90/10 Disclosure

 

The Company derives a substantial portion of its revenues from student financial aid received by its students under the Title IV programs administered by ED pursuant to the Higher Education Act. To continue to participate in the student financial aid programs, the Company must comply with the regulations promulgated under the Higher Education Act. The regulations restrict the proportion of cash receipts for tuition and fees from eligible programs to not more than 90% from Title IV programs (the “90/10 revenue test”). If an institution fails to satisfy the test for one year, its participation status becomes provisional for two consecutive fiscal years. If the test is not satisfied for two consecutive years, eligibility to participate in Title IV programs is lost for at least two fiscal years. Using ED’s cash-basis, regulatory formula under the 90/10 Rule, as in effect for its 2023 fiscal year, HDMC, CCC and Integrity derived 84.53%,75.48% and 88.14% for its 90/10 revenue from Title IV program funds, respectively. The 90/10 calculation for fiscal year ended June 30, 2024 has not yet been completed as of the date of these financial statements and is due on December 31, 2024.

 

Litigation

 

The Company does not believe it is a party to any other pending or threatened litigation arising from services currently or formerly performed by the Company. To the extent that there may be other pending or threatened litigation that management is unaware of, they do not believe there to be any possible claims that could have a material adverse effect on their business, results of operations or financial condition.

 

F-19

 

 

Note 15 – Subsequent Events

 

Subsequent to September 30, 2024 the Company issued an additional 375,000 common shares in respect to the underwriters’ option to purchase up to an additional 375,000 shares of common stock to cover allotments.

 

On October 22, 2024, Legacy Education Antioch, LLC, a wholly-owned subsidiary of Legacy LLC (as defined herein) (the “Buyer”) entered into an asset purchase agreement (the “APA”) with Legacy Education Inc. (the “Company”), Legacy Education, LLC, a wholly-owned subsidiary of the Company (“Legacy LLC” and together with the Company and the Buyer, the “Buyer Parties”), Contra Costa Medical Career College, Inc. (“CCMCC”), Contra Costa Medical Career College Online, Inc. (“CCMCC Online” and together with CCMCC, “Sellers”) and, solely with respect to certain portions of the APA, Stacey Orozco and Bulmaro Orozco, the sole owners CCMCC and CCMCC Online (collectively, the “Owners”).

 

Pursuant to the APA, Buyer shall acquire from the Sellers substantially all of the assets comprising of the postsecondary institution known as Contra Costa Career Medical College located in Antioch, California upon the terms and conditions set forth in the APA for a purchase price of $8,000,000, subject to adjustment as set forth in the APA (the “Purchase Price”). The Purchase Price shall be payable as follows: (i) $6,600,000 shall be payable upon the closing (the “Closing”) of the transactions contemplated by the APA (the “Transaction”), subject to adjustment as set forth in the APA; (ii) the Buyer shall deliver to the Sellers a promissory note (the “Note”) in the principal amount of $400,000 which Note shall be guaranteed by the Company and Legacy LLC, accrue interest at a rate of 6% per annum and shall be payable in 12 equal monthly installments beginning on the one-month anniversary of the closing date of the Transaction and shall be subject to offsets by the Buyer for any Purchase Price Adjustment Payment (as defined in the APA) owed by Sellers pursuant to the APA and for any indemnification claims made by Buyer pursuant to the APA that are not fully resolved prior to the due date of any one or more of the payments due under such Note; and (iii) the issuance, for the benefit of the Sellers, to CCMCC of such number of shares of the Company’s common stock (the “Legacy Shares”) equal to $1,000,000, which number of shares shall be determined based upon the value of the Company’s common stock as of the close of business on the business day immediately preceding the closing date of the Transaction. The Legacy Shares shall be held in escrow for a period of one year following the Closing and shall be subject to any indemnification claims made by the Buyer pursuant to the APA that are not fully resolved and satisfied prior to the end of such one-year period either by payments made by Sellers or by offsets made by Buyer against any one or more of the payments due under the Note.

 

Pursuant to the APA, the Sellers shall enter into a consulting agreement with the Buyer pursuant to which the Sellers will, for a period of 180 days following the Closing, make available to Buyer, upon its request, the services of the Owners, to provide transitional consulting assistance to Buyer. In addition, pursuant to the APA, the Owners have agreed to assist the Buyer in negotiating an agreement with Contra Costa Clinic pursuant to which Contra Costa Clinic shall continue providing its services to the college following the Closing, on terms reasonably satisfactory to the Buyer. The Buyer shall also enter into a lease agreement with Evergreen Properties SBLD, LLC, the owner of the college campus property.

 

F-20

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, this discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 as may be amended, supplemented or superseded from time to time by other reports we file with the SEC. All amounts in this report are in U.S. dollars, unless otherwise noted.

 

Throughout this Quarterly Report on Form 10-Q references to “we,” “our,” “us,” the “Company,” or “Legacy,” refer to Legacy Education Inc.

 

Overview

 

We provide career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents, through our accredited academic institutions: High Desert Medical College, which we acquired in July 2010, Central Coast College, which we acquired in January 2019, and Integrity College of Health. On December 31, 2019, we entered into a Membership Interest Purchase Agreement with the sole member of Integrity. We purchased from the sole member of Integrity on that date 24.5% of her interest and obtained an exclusive option to acquire her remaining membership interest upon payment of $100, which was exercised on September 15, 2020. For purposes of our financial statements, the acquisition of Integrity is deemed to have been effective as of December 31, 2019.

 

High Desert Medical College

 

HDMC was established in the State of California in 2002 and began offering classes in 2003. It started with campuses in Lancaster, California, and added its first branch in 2008 in Bakersfield, California. Due to enrollment growth and high demand for its services, HDMC expanded to add a branch campus in Temecula, California campus in order to accommodate 250 to 400 additional students. HDMC offers UT, VN, VN Associate of Applied Science degree program, Associate Degree of Nursing, nursing assistant, MRI Associate of Applied Science, cardiac sonography, pharmacy technician, dental assisting, clinical medical assisting, medical administrative assisting programs, medical billing and coding, veterinary assistant, phlebotomy technician avocational, nursing assistant avocational, and UT Associate of Applied Science degree programs. HDMC also plans to offer an emergency medical technician (EMT) program beginning in October 2024 and is in the process of obtaining approvals for the program (for which HDMC is not planning to apply for ED approval to make Title IV Program funds available for students who enroll in the program). As of September 30, 2024, HDMC had 1,885 students enrolled in its programs.

 

Central Coast College

 

CCC was established in the State of California in 1983. In 1991, CCC moved to its current location in Salinas, California to accommodate growing enrollment numbers and the addition of new training programs.

 

CCC offers the following certificate or degree programs: business administrative specialist, computer specialist: accounting, medical administrative assistant, medical assisting, nursing assistant, UT, UT Associate of Applied Science, veterinary assistant, veterinary technology Associate of Applied Science, and VN. CCC also offers an avocational phlebotomy technician program. CCC also has obtained approval from ACCET to offer the following programs and plans to begin doing so in October 2024, pending additional approvals: surgical technology (Associate of Applied Science), dental assisting, and sterile processing technician. CCC is also in the process of applying for approvals for a pharmacy technician program and an Associate Degree in Nursing program that it intends to provide in the future. As of September 30, 2024, CCC had 485 students enrolled in its programs.

 

1

 

 

Integrity College of Health

 

Integrity was established in the State of California in 2007. Integrity’s campus is located in Pasadena, California. Integrity offers VN, VN Associate of Applied Science, Registered Nurse to Bachelor of Science in Nursing (“RN to BSN”), medical assisting, medical billing and coding, veterinary assistant, and Diagnostic Medical Sonography programs. Integrity also plans to offer an emergency medical technician (EMT) program beginning in October 2024 and is in the process of obtaining approvals for the program (for which Integrity is not planning for ED approval to make Title IV funds available for students who enroll in the program). For purposes of our financial statements, Legacy Education, L.L.C. is deemed to have acquired Integrity in December 2019. As of September 30, 2024, Integrity had 169 students enrolled in its programs.

 

Recent Developments

 

Regulatory Updates

 

Acquisition Agreement with Contra Costa Medical Career College

 

As previously reported on a Current Report on Form 8-K filed with the SEC, on October 22, 2024, Legacy Education Antioch, LLC, a wholly-owned subsidiary of Legacy LLC (as defined herein) (the “Buyer”) entered into an asset purchase agreement (the “APA”) with Legacy Education Inc. (the “Company”), Legacy Education, LLC, a wholly-owned subsidiary of the Company (“Legacy LLC” and together with the Company and the Buyer, the “Buyer Parties”), Contra Costa Medical Career College, Inc. (“CCMCC”), Contra Costa Medical Career College Online, Inc. (“CCMCC Online” and together with CCMCC, “Sellers”) and, solely with respect to certain portions of the APA, Stacey Orozco and Bulmaro Orozco, the sole owners CCMCC and CCMCC Online (the “CCMCC Transaction”).

 

When a company acquires an institution that is eligible to participate in the Title IV Programs, like CCMCC, the acquisition generally will result in the institution undergoing a change of ownership resulting in a change of control as defined by ED and under the rules of other educational agencies and accreditors. Upon such a change, an institution’s eligibility to participate in the Title IV Programs is generally suspended until it has applied for recertification by ED as an eligible school under its new ownership, which requires that the school also re-establish its state authorization and accreditation. ED may temporarily and provisionally certify an institution seeking approval of a change of control under certain circumstances while ED reviews the institution’s application. The temporary provisional certification typically remains in effect on a month-to-month basis during ED’s review of the application as long as the school timely submits certain documentation during the course of ED’s review. We cannot predict the timing or outcome of ED’s review of the change of ownership of CCMCC.

 

The time required for ED to act on such an application may vary substantially. ED recertification of an institution following a change of control will be on a provisional basis if ED approves the institution’s application and could contain restrictions or conditions depending on the outcome of its review of the institution under the new ownership including its administrative capability and financial stability. Under ED regulations that took effect July 1, 2023, an institution must submit certain information and documentation at least 90 days in advance of the change in ownership including, for example, notice to current and prospective students of the planned change in ownership. The parties have submitted this documentation to ED. If ED contends that the documentation is insufficient and we are unable to take timely corrective action, we could be required to delay the closing of the transaction.

 

The approval processes for state and accrediting agencies vary in scope and timing with some agencies requiring approval prior to the acquisition and others not conducting their review until after the acquisition has taken place. With regard to the agencies that accredit CCMCC and CCMCC Online, authorize them to operate in the state of California, or approve their programs:

 

  California Bureau for Private Postsecondary Education (“BPPE”): Institutions that are licensed by BPPE by means of accreditation, like CCMC, are required to notify BPPE of the change within 30 days of the change and demonstrate that the substantive change was made in accordance with the institution’s accreditation standards.

 

2

 

 

  Accrediting Council for Continuing Education and Training (“ACCET”): ACCET accreditation standards require that institutions undergoing a change in ownership or control submit notice at least ten days prior to a prospective agreement for the change.  ACCET also requires submission of an application for approval of the change in ownership or control within ten days following the change.  
  California State Approving Agency for Veterans Education (“CSAAVE”): CSAAVE requires approved institutions to make  a post-change submission to CSAAVE for approval of the change when there has been a material change to the institution’s current approval.  
  Accreditation Bureau of Health Education Schools (“ABHES”):  ABHES requires institutions that hold ABHES programmatic accreditation to notify it of any change in organizational oversight or legal structure, and to submit a completed application for change in legal status, ownership, or control within five days after the change.
  California Board of Vocational Nursing and Psychiatric Technicians (“BVNPT”):  The parties plan to provide notice to BVNPT after the transaction occurs and to respond to any subsequent instructions from the agency.
  California Department of Public Health, Laboratory Field Services (“CDPH”):  CDPH requires certain training programs undergoing a change of ownership to notify CDPH within 30 days after the change has occurred and submit a new application package.

 

If agencies require us to obtain approvals in connection with the CCMCC Transaction, we will be required to undergo an application process for approvals from the applicable agencies and could be subject to conditions or restrictions (or loss of approval) depending on the outcome of the approval process. We will be required to make or obtain notices and/or approvals prior to the CCMCC Transaction from those agencies that require notice and/or approval to be made or obtained prior to the occurrence of a change in ownership or control. If we move forward with the CCMCC Transaction without making or obtaining required pre-closing notices and approvals, we could be subject to sanctions by the applicable agencies including loss of CCMCC’s approvals from these agencies.

 

Key Financial Metrics

 

Revenue

 

Tuition revenue is primarily derived from postsecondary education services provided to students. Generally, tuition and other fees are paid upfront and recorded in contract liabilities in advance of the date when education services are provided to the student. A tuition receivable is recorded for the portion of tuition not paid in advance. In some instances, installment billing is available to students which reduces the amount of cash consideration received in advance of performing the service. The contractual terms and conditions associated with installment billing indicate that the student is liable for the total contract price, therefore mitigating the Company’s exposure to losses associated with nonpayment. Tuition revenue is recognized ratably over the instruction period. The Company generally uses the time elapsed method, an input measure, as it best depicts the simultaneous consumption and delivery of tuition services. Revenue associated with distinct course materials is recognized at the point of time when control transfers to the student, generally when the materials are delivered to the student. Revenue associated with lab services is recognized over the period of time when the service is performed.

 

Enrollments

 

Enrollments are a function of the number of continuing students at the beginning of each period and new enrollments during the period, offset by students who either graduated or withdrew during the period.

 

Costs and expenses

 

Educational service. This expense consists primarily of costs related to the administration and delivery of educational programs by our academic institutions. This expense category includes salaries, benefits, share-based compensation, student books, student supplies and occupancy costs.

 

3

 

 

General and administrative. This expense includes bad debt expense, share-based compensation, legal and professional fees, insurance, accreditation fees, and travel of employees engaged in corporate management, finance, human resources, compliance and other corporate functions. This expense also includes marketing and advertising costs, which are expensed in the fiscal year incurred.

 

Depreciation and amortization. This expense reflects depreciation and amortization of property and equipment, amortization of assets under capital leases and amortization of intangible assets.

 

Interest expense

 

This expense reflects interest paid under notes issued to our investors, IRS interest, non-cash interest related to unit option grants, interest related to notes associated with CCC, and other debt related interest.

 

Interest income

 

This income relates to interest received from investments.

 

Factors Affecting Comparability

 

We believe the following factors have had, or can be expected to have, a significant effect on the comparability of recent or future results of operations:

 

Seasonality

 

Our operations are generally subject to seasonal trends. We generally experience a seasonal increase in new enrollments during the first quarter of our fiscal year, as well as during the third quarter each year, when most other colleges and universities begin their fall semesters and subsequent to holiday break. While we enroll students throughout the year, our second quarter revenue generally is lower than other quarters due to the holiday season.

 

Critical Accounting Policies and Use of Estimates

 

The preparation of the financial statements included elsewhere in this Quarterly Report on Form 10-Q requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results could differ from these estimates.

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the evaluation of the Company’s distinct performance obligations, the valuation of equity instruments and valuation allowances for credit losses related to accounts receivable.

 

Allowance for credit losses

 

We record an allowance for doubtful credit losses for estimated losses resulting from the inability, failure or refusal of our students to make required payments, which includes the recovery of financial aid funds advanced to a student for amounts in excess of the student’s cost of tuition and related fees. We determine the adequacy of our allowance for doubtful accounts based on an analysis of our historical bad debt experience, current economic trends, and the aging of the accounts receivable and student status. We apply reserves to our receivables based upon an estimate of the risk presented by the age of the receivables and student status. We write off account receivable balances of inactive students at the earlier of the time the balances were deemed uncollectible, or one year after the revenue is generated. Bad debt expense is recorded as a general and administrative expense in the income statement. The Company performs an analysis annually to determine which accounts are uncollectable and write them off.

 

4

 

 

Impairment of long-lived assets

 

We evaluate the recoverability of our long-lived assets for impairment, other than goodwill, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to undiscounted future net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Fair value estimates are based on assumptions concerning the amount and timing of estimated future cash flows. We had [no long-lived asset impairments as of September 30, 2024 and June 30, 2023, respectively.]

 

Income taxes

 

GAAP requires management to evaluate tax positions taken by us and recognize a tax liability if we have taken an uncertain position that is more likely than not would be sustained upon examination by the Internal Revenue Service. Management has analyzed our tax positions and believes there are no uncertain positions taken or expected to be taken that would require recognition of a liability or disclosure in the financial statement.

 

Corporate tax applies to corporations and limited liability companies that elect to be treated as corporations. The federal income tax rate for c-corporations is 21% and the state tax rate is 8.84%, and it applies to net taxable income from business activity in California.

 

Corporations are not subject to the state’s franchise tax, but they are subject to the alternative minimum tax (“AMT”) of 6.65%, which limits the effectiveness of a business writing off expenses against income to lower its corporate tax rate. C-corporations pay the state corporate tax of 8.84% or AMT of 6.65%, depending on whether they claim net taxable income.

 

We account for income taxes payable or refundable for the current year and deferred tax assets and liabilities for future tax consequences of events that have been recognized in our financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which the temporary differences are expected to be realized.

 

Share Based Compensation

 

The Company utilizes ASC 718, Stock Compensation, related to accounting for share-based payments and, accordingly, records compensation expense for share-based awards based upon an assessment of the grant date fair value for stock options and restricted stock awards. The Company estimates the fair value of stock-based compensation awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s consolidated statements of operations. The Company estimates the fair value of stock-based compensation awards using the Black-Scholes model. This model requires the Company to estimate the expected volatility and value of its common stock and the expected term of the stock options, all of which are highly complex and subjective variables. The expected life was calculated based on the simplified method as described by the SEC Staff Accounting Bulletin No. 110, Share-Based Payment. The Company’s estimate of expected volatility was based on the volatility of peers. The Company has selected a risk-free rate based on the implied yield available on U.S. Treasury securities with a maturity equivalent to the expected term of the options. The Company accounts for forfeitures upon occurrence.

 

Goodwill and Other Indefinite-lived Assets

 

We test goodwill and other indefinite-lived assets for impairment at least annually, or more frequently if events or changes in circumstances indicate that the asset may be impaired. There were no goodwill or other indefinite-lived intangible asset impairments for the periods presented, and based on current qualitative impairment tests, goodwill and other indefinite-lived intangible assets are not as risk of failing.

 

5

 

 

Results of Operations

 

Three Months Ended September 30, 2024 Compared to Three Months Ended September 30, 2023

 

The following table sets forth our consolidated statements of income data as a percentage of revenue for the three months ended September 30, 2024 and 2023:

 

   Three months ended
September 30,
   Percentage
Change
 
   2024   2023   (decrease) 
Revenue   100%   100%     
Costs and expenses:               
Educational services   51.4%   55.3%   -3.9%
General and administrative   28.3%   30.4%   -2.1%
General and administrative – related party   0.6%   0.4%   0.2%
Depreciation and amortization   0.6%   0.6%   0.0%
Total costs and expenses   80.9%   86.7%   -5.8%
Operating income   19.1%   13.3%   5.8%
Interest expense   -0.2%   -0.3%   0.1%
Interest income   1.8%   1.4%   0.4%
Income before income taxes   20.7%   14.4%   6.3%
Income tax expense   -5.8%   -4.1%   -1.7%
Net income   14.9%   10.3%   4.6%

 

Revenue. Our revenue was approximately $14.0 million for the three months ended September 30, 2024 compared to approximately $10.4 million for the three months ended September 30, 2023, an increase of approximately $3.6 million, or approximately 35.1%. The increase is primarily due to a 25.4% increase in ending enrollment from 2,024 to 2,539 supported by a 23.3 increase in starts from 627 to 773 in the quarter compared to prior year. Additionally, we experienced favorable program mix to higher earning programs within the quarter.

 

Educational services. Our educational services expense was approximately $7.2 million for the three months ended September 30, 2024 compared to approximately $5.7 million for the three months ended September 30, 2023, an increase of approximately $1.5 million, or approximately 25.7%. The increase was primarily attributable to the increased instructional and staffing required to support the increase in enrollments as well as increased rent and externship fees.

 

General and administrative expense. Our general and administrative expense was approximately $4.0 million for the three months ended September 30, 2024 compared to approximately $3.2 million for the three months ended September 30, 2023, an increase of approximately $0.8 million, or approximately 25.7%. The increase was primarily attributable to an increase in marketing expense, professional fees and bad debt expense. Of the total general and administrative expense, $1.2 million and $1.1 million relate to marketing expense relate for the first quarter of fiscal 2025 and 2024, respectively.

 

Depreciation and amortization. Our depreciation and amortization expense was approximately $0.1 million for the three months ended September 30, 2024 compared to approximately $0.1 million for the three months ended September 30, 2023.

 

Interest expense. Our interest expense was approximately $0.0 for the three months ended September 30, 2024 compared to approximately $0.0 for the three months ended September 30, 2023.

 

Income tax expense. Our income tax expense was approximately $0.8 million for the three months ended September 30, 2024 compared to approximately $0.4 million for the three months ended September 30, 2023, an increase of approximately $0.4 million, or approximately 90.9%. The increase is primarily attributable to increase in income.

 

Net Income. Our net income was approximately $2.1 million for the three months ended September 30, 2024 compared to approximately $1.1 million for the three months ended September 30, 2023, an increase of approximately $1.0 million, or approximately 95.5%, due to the reasons mentioned above.

 

6

 

 

Liquidity and Capital Resources

 

Our cash and cash equivalents were approximately $21.5 million and $10.4 million as of September 30, 2024, and 2023, respectively.

 

We are not party to a revolving line of credit or other debt facility.

 

Based on our current level of operations and anticipated growth, we believe that our cash flow from operations, the proceeds from our initial public offering and other sources of liquidity, including cash and cash equivalents, will provide adequate funds for ongoing operations, planned capital expenditures and working capital requirements for at least the next 12 months.

 

Capital expenditures were approximately $0.2 million and $0.2 million for three months ended September 30, 2024, and 2023, respectively.

 

Title IV and other government funding

 

A significant portion of our revenue is derived from student tuition payments funded by the Title IV Programs. As such, the timing of disbursements under the Title IV Programs is based on federal regulations and our ability to successfully and timely arrange financial aid for our students. Title IV Program funds are generally provided in multiple disbursements before we earn a significant portion of tuition and fees and incur related expenses over the period of instruction. Students must apply for new Title IV Program loans and grants each academic year. These factors, together with the timing of our students beginning their programs, affect our operating cash flow.

 

Financial responsibility

 

Based on the most recent fiscal year-end financial statements, we satisfied the composite score requirement of the financial responsibility test which institutions must satisfy in order to participate in the Title IV Programs.

 

Cash Flow Activities for the Three Months Ended September 30, 2024 and 2023

 

Operating activities

 

Net cash provided by operating activities was approximately $3.2 million and $0.5 million for the three months ended September 30, 2024, and 2023, respectively. The increase of approximately $1.0 million is primarily attributable to an increase in earnings and an increase of approximately $2.7 million related to deferred unearned tuition.

 

Investing activities

 

Net cash used in investing activities was approximately $0.2 million for the three months ended September 30, 2024, and approximately $0.2 million for the three months ended September 30, 2023, an increase of approximately $0.1 million.

 

Financing activities

 

Net cash provided by financing activities was approximately $8.2 million for the three months ended September 30, 2024, and net cash used of approximately $0.2 million for the three months ended September 30, 2023, an increase of approximately $8.4 million due to the net proceeds of $7.9 million from our initial public offering (“IPO”).

 

Financings

 

From July 2021 to September 2021, the Company issued 108,333 shares of common stock to investors at a purchase price of $3.00 per share for total proceeds of $325,000.
   
From July 2022 to June 2023, the Company issued dividends of $929,116
   

From July 2024 to September 2024, the Company issued 2,500,000 shares of common stock as part of its IPO at a price of $4.00 per share for gross proceeds of $10,000,000

 

7

 

 

Impact of Inflation

 

We believe that inflation has not had a material impact on our results of operations for the three months ended September 30, 2024, and 2023. There can be no assurance that future inflation will not have an adverse impact on our operating results and financial condition.

 

Segment Information

 

We operate in one reportable segment as a single educational delivery operation using a core infrastructure that serves the curriculum and educational delivery needs of our institution’s students regardless of geography. Our chief operating decision maker, our CEO and President, manages our operations as a whole, and our chief operating decision maker does not evaluate expenses or operating income information on a component level.

 

Recent Accounting Pronouncements

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under current GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2021, using a modified retrospective approach and early adoption is permitted. The Company adopted ASU 2016-02 on July 1, 2022. The Company has elected to apply the short-term scope exception for leases with terms of 12 months or less at the inception of the lease and will continue to recognize rent expense on a straight-line basis. As a result of the adoption, on July 1, 2022, the Company recognized a lease liability of approximately $5.7 million, which represented the present value of the remaining minimum lease payments using an estimated incremental borrowing rate of 3.98%. As of July 1, 2022, the Company recognized a right-to-use asset of approximately $5.3 million. Lease expense did not change materially as a result of the adoption of ASU 2016-02.

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 provides guidance for recognizing credit losses on financial instruments based on an estimate of current expected credit losses model. The amendments are effective for fiscal years beginning after December 15, 2019. Recently, the FASB issued the final ASU to delay adoption for smaller reporting companies for fiscal years beginning after December 15, 2022. We adopted ASU 2016-13 on July 1, 2023 and it did not have a material impact on our consolidated financial statements and related disclosures.

 

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity’s own equity, and also improves and amends the related earnings per share guidance for both Subtopics. The ASU will be effective for smaller reporting companies for annual reporting periods beginning after December 15, 2023 and interim periods within those annual periods and early adoption is permitted. We adopted 2020-06 on July 1, 2024 and it did not have a material impact on our consolidated financial statements and related disclosures.

 

8

 

 

JOBS Act

 

On April 5, 2012, the JOBS Act was enacted. Section 107 of the JOBS Act provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act, for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

 

We have chosen to take advantage of the extended transition periods available to emerging growth companies under the JOBS Act for complying with new or revised accounting standards until those standards would otherwise apply to private companies provided under the JOBS Act. As a result, our financial statements may not be comparable to those of companies that comply with public company effective dates for complying with new or revised accounting standards.

 

We are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, as an “emerging growth company,” we intend to rely on certain of these exemptions, including, without limitation, (i) providing an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act and (ii) complying with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. We will remain an “emerging growth company” until the earliest of (i) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more, as such amount is indexed for inflation every five years by the Securities and Exchange Commission to reflect the change in the Consumer Price Index for All Urban Consumers during its most recently completed fiscal year; (ii) the last day of our fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (iii) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is not required to provide the information required by this Item as it is a “smaller reporting company,” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Our principal executive officer and principal financial officer evaluated the effectiveness of our “disclosure controls and procedures” as of September 30, 2024, the end of the period covered by this Quarterly Report on Form 10-Q. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is accumulated and communicated to a company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and recognizes that any control and procedures, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Based on the evaluation of our disclosure controls and procedures as of September 30, 2024, our Chief Executive Officer and our Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.

 

Changes in Internal Control

 

There have been no significant changes in our internal control over financial reporting during the three months ended September 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

9

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may be subject to litigation and claims arising in the ordinary course of business. We are not currently a party to any material legal proceedings and we are not aware of any pending or threatened legal proceeding against us that we believe could have a material adverse effect on our business, operating results, cash flows or financial condition.

 

ITEM 1A. RISK FACTORS

 

Risk factors that affect our business and financial results are discussed in Part I, Item 1A “Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2024 as filed with the SEC on October 1, 2024 (“Annual Report”). There have been no material changes in our risk factors from those previously disclosed in our Annual Report. You should carefully consider the risks described in our Annual Report which could materially affect our business, financial condition or future results. The risks described in our Annual Report are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and/or operating results. If any of the risks actually occur, our business, financial condition, and/or results of operations could be negatively affected.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

(a) Sales of Unregistered Securities.

 

None.

 

(b) Use of IPO Proceeds.

 

On September 27, 2024, we completed our IPO pursuant to which we issued and sold 2,500,000 shares of common stock at a price of $4.00 per share. We also issued 375,000 shares of common stock issued pursuant to the exercise by the underwriters of their over-allotment option, at a price to the public of $4.00 per share in the second quarter of fiscal 2025. The securities were sold pursuant to our Registration Statement on Form S-1 (File No. 333-281586) which was declared effective by the SEC on September 25, 2024.

 

We received net proceeds of approximately $7.9 million from the sale of the 2,500,000 shares of common stock after deducting underwriting discounts and commissions and offering expenses We also received net proceeds of approximately $1.4 million, which includes 375,000 shares of common stock issued pursuant to the exercise by the underwriters of their over-allotment option, after deducting underwriting discounts and commissions and offering expenses.

 

The offering commenced on September 25, 2024, and did not terminate before all securities registered in the registration statement were sold.

 

None of the expenses incurred by us were direct or indirect payments to any of (i) our directors or officers or their associates, (ii) persons owning 10% or more of our common stock, or (iii) our affiliates. Northland Securities, Inc., acted as book-running manager and representative of the underwriters for the IPO.

 

There has been no material change in the planned use of proceeds from our IPO from that described in the final prospectus related to the offering, dated September 25, 2024, as filed with the SEC on September 27, 2024.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

10

 

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

Rule 10b5-1 Trading Plans

 

During the three months ended September 30, 2024, none of the Company’s directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description
31.1*   Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 is formatted in Inline XBRL

 

  * Filed herewith.
** Furnished herewith.

 

11

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  LEGACY EDUCATION INC.
   
Date: November 14, 2024 By: /s/ LeeAnn Rohmann
    LeeAnn Rohmann
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: November 14, 2024 By: /s/ Brandon Pope
    Brandon Pope
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

12